Navigation Links
Vasogen Announces First Quarter 2009 Results
Date:4/13/2009

nt - - 125 Gain on sale of patents (487) - (487) Accretion in carrying value of senior convertible notes payable - - 10,294 Amortization of deferred financing costs - - 3,057 Loss on extinguishment of senior convertible notes payable - - 6,749 Change in fair value of embedded derivatives - - (829) Stock-based compensation 416 235 10,806 Common shares issued for services - - 2,485 Unrealized foreign exchange gain (38) 192 11,381 Other - - (35) Change in non-cash operating working capital 299 1,398 737 ----------------------------------------------------------------------- (1,749) (3,433) (341,693) Financing activities: Shares and warrants issued for cash - - 326,358 Warrants exercised for cash - - 16,941 Options exercised for cash - - 7,669 Share issue costs - - (24,646) Repayment of senior convertible notes payable, net - - 38,512 Paid to related parties - - (234) ----------------------------------------------------------------------- -
'/>"/>
SOURCE Vasogen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vasogen Announces 2008 Year-End Results
2. Vasogen Announces Sale of Patent Application and Provides Corporate Update
3. Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1)
4. Vasogen Provides Corporate Update
5. Vasogen Announces Third Quarter 2008 Results
6. Vasogen Announces Second Quarter 2008 Results
7. Vasogen Provides Corporate Update
8. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
10. Vasogen Announces Implementation of Strategic Restructuring Plan
11. Vasogen Announces First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Calif. , Aug. 4, 2015 Trigemina, ... development of non-narcotic, nasally delivered, analgesic drug products, announced ... M.D., to the position of chief medical officer. Dr. ... to Trigemina, much of which has been focused in ... thrilled to add Dr. Kori to our clinical team ...
(Date:8/4/2015)... SAN CARLOS, Calif. , Aug. 4, 2015 /PRNewswire/ ... non-invasive genetic testing and the analysis of circulating cell-free ... its second quarter ended June 30, 2015 after the ... a conference call and webcast at 1:30 p.m. PT ... activities and financial outlook.Event:Natera,s Second Quarter 2015 Results Conference ...
(Date:8/3/2015)... , Aug. 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... Call for the second quarter 2015 on Monday, August ... Helen Torley , president and chief executive officer, ... Halozyme will release financial results for the second quarter ... through the "Investors" section of Halozyme,s corporate website and ...
(Date:8/3/2015)... UK (PRWEB) , ... August 03, 2015 , ... ... consumer of benzene. Benzene is processed to get such derivatives as ethylbenzene, a ... derivatives are principally used within the automotive industry for the production of tyres ...
Breaking Biology Technology:Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3Natera to Release Second Quarter 2015 Results on August 12, 2015 2Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3
... , ... Real-time in situ FTIR analysis has become a standard tool ... allows a more thorough understanding of reactions during the development and scale-up ... the Development of Batch and Continuous Chemical Processes Using Real-Time In Situ ...
... , ... Canadian Therapy Uses Energy Physics To Target Tissues Affected by Osteoarthritis. Physics and Biology ... ... announced today that its home-use medical device, the MyPhield Arthritis Therapy Cushion that naturally ...
... Nov. 3 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ... September 30, 2009. ISTA reported net revenue of $32.0 ... 47% increase over net revenue for the three months ended ... three months ended September 30, 2009 is $1.2 million associated ...
Cached Biology Technology:Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool 2New Technology Now Available In Canada For Osteoarthritis 2ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 2ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 3ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 4ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 5ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 6ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 7ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 8ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 9
(Date:7/2/2015)... , June 25, 2015 ... of the "Next Generation Biometrics Market by Application, ... report to their offering. The next ... by 2020, at a CAGR of 17.9% between 2015 ... leading application for the market. Safran SA ...
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2
... bacteria of its ability to resist an antibiotic in ... health crisis. Rice environmental engineer Pedro Alvarez ... the Pseudomonas aeruginosa microorganism to resist the antibiotic medication ... Over 120 generations, the starving bacteria chose ...
... Bethesda, MD The Federation of American Societies for ... the Science Research Conference (SRC): Melatonin Biology: Actions & ... Biology: Actions & Therapeutics is an important and unique ... as a cytoprotective molecule and a physiological marker of ...
... behave differently. However, that difference isn,t taken into account ... children from chemical exposure, according to Cheryl Rosenfeld, associate ... Bond Life Sciences Center. A series of experiments by ... A (BPA) on later reproductive-associated behaviors using a socially ...
Cached Biology News:Lack of energy an enemy to antibiotic-resistant microbes 2Lack of energy an enemy to antibiotic-resistant microbes 3Bisphenol A affects sex-specific reproductive behaviors in a monogamous animal species 2